Luteolin attenuates Wnt signaling via upregulation of FZD6 to suppress prostate cancer stemness revealed by comparative proteomics
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Luteolin attenuates Wnt signaling via upregulation of FZD6 to suppress prostate cancer stemness revealed by comparative proteomics
Authors
Keywords
-
Journal
Scientific Reports
Volume 8, Issue 1, Pages -
Publisher
Springer Nature
Online
2018-05-29
DOI
10.1038/s41598-018-26761-2
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A validated algorithm for selecting non-toxic chemical concentrations
- (2018) Julita Stadnicka-Michalak ALTEX-Alternatives to Animal Experimentation
- Luteolin, a novel p90 ribosomal S6 kinase inhibitor, suppresses proliferation and migration in leukemia cells
- (2017) Lan Deng et al. Oncology Letters
- Non-canonical WNT/PCP signalling in cancer: Fzd6 takes centre stage
- (2017) G Corda et al. Oncogenesis
- Proteomics and drug discovery in cancer
- (2016) Matheus H. Dias et al. DRUG DISCOVERY TODAY
- Molecular targets of luteolin in cancer
- (2016) Muobarak J. Tuorkey EUROPEAN JOURNAL OF CANCER PREVENTION
- Functional and prognostic significance of the genomic amplification of frizzled 6 (FZD6 ) in breast cancer
- (2016) Gabriele Corda et al. JOURNAL OF PATHOLOGY
- Drug discovery in advanced prostate cancer: translating biology into therapy
- (2016) Timothy A. Yap et al. NATURE REVIEWS DRUG DISCOVERY
- Luteolin inhibited proliferation and induced apoptosis of prostate cancer cells through miR-301
- (2016) Kun Han et al. OncoTargets and Therapy
- A regulatory circuit of miR-125b/miR-20b and Wnt signalling controls glioblastoma phenotypes through FZD6-modulated pathways
- (2016) Tianzhi Huang et al. Nature Communications
- EBV reactivation as a target of luteolin to repress NPC tumorigenesis
- (2016) Chung-Chun Wu et al. Oncotarget
- High-Throughput Single-Cell Derived Sphere Formation for Cancer Stem-Like Cell Identification and Analysis
- (2016) Yu-Chih Chen et al. Scientific Reports
- Luteolin as an anti-inflammatory and neuroprotective agent: A brief review
- (2015) Seyed Fazel Nabavi et al. BRAIN RESEARCH BULLETIN
- Generation of a Selective Small Molecule Inhibitor of the CBP/p300 Bromodomain for Leukemia Therapy
- (2015) S. Picaud et al. CANCER RESEARCH
- Targeting Cancer Stem Cells in Castration-Resistant Prostate Cancer
- (2015) E.-J. Yun et al. CLINICAL CANCER RESEARCH
- Prostate Cancer Stem Cells: Research Advances
- (2015) Dagmara Jaworska et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Inhibition of p300 lysine acetyltransferase activity by luteolin reduces tumor growth in head and neck squamous cell carcinoma (HNSCC) xenograft mouse model
- (2015) Ruthrotha B. Selvi et al. Oncotarget
- Fisetin and luteolin protect human retinal pigment epithelial cells from oxidative stress-induced cell death and regulate inflammation
- (2015) Maria Hytti et al. Scientific Reports
- Frizzled receptor 6 marks rare, highly tumourigenic stem-like cells in mouse and human neuroblastomas.
- (2015) Sandra Cantilena et al. Oncotarget
- Advanced prostate cancer – patient survival and potential impact of enzalutamide and other emerging therapies
- (2014) Jeanny Aragon-Ching et al. Therapeutics and Clinical Risk Management
- Flavonoids as receptor tyrosine kinase FLT3 inhibitors
- (2013) Young-Won Chin et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Induction of endoplasmic reticulum stress-mediated apoptosis and non-canonical autophagy by luteolin in NCI-H460 lung carcinoma cells
- (2013) Shin-Hyung Park et al. FOOD AND CHEMICAL TOXICOLOGY
- Luteolin Induces Growth Arrest in Colon Cancer Cells Through Involvement of Wnt/β-Catenin/GSK-3β Signaling
- (2013) Ashok Kumar Pandurangan et al. JOURNAL OF ENVIRONMENTAL PATHOLOGY TOXICOLOGY AND ONCOLOGY
- The side effects of hormonal therapy at the patients with carcinoma of prostate cancer
- (2013) Ewa Ziółkowska et al. Wspolczesna Onkologia-Contemporary Oncology
- Luteolin decreases IGF-II production and downregulates insulin-like growth factor-I receptor signaling in HT-29 human colon cancer cells
- (2012) Do Young Lim et al. BMC GASTROENTEROLOGY
- Autophagy Inhibitor Chloroquine Enhanced the Cell Death Inducing Effect of the Flavonoid Luteolin in Metastatic Squamous Cell Carcinoma Cells
- (2012) Lien Verschooten et al. PLoS One
- The role of targeted chemical proteomics in pharmacology
- (2011) Chris W Sutton BRITISH JOURNAL OF PHARMACOLOGY
- Discovering Natural Product Modulators to Overcome Multidrug Resistance in Cancer Chemotherapy
- (2011) Chung-Pu Wu et al. CURRENT PHARMACEUTICAL BIOTECHNOLOGY
- Bipolar androgen therapy: The rationale for rapid cycling of supraphysiologic androgen/ablation in men with castration resistant prostate cancer
- (2010) Samuel R. Denmeade et al. PROSTATE
- WNT signaling regulates self-renewal and differentiation of prostate cancer cells with stem cell characteristics
- (2009) Isabelle Bisson et al. CELL RESEARCH
- Luteolin inhibits cell proliferation during Azoxymethane-induced experimental colon carcinogenesis via Wnt/ β-catenin pathway
- (2009) Pandurangan Ashokkumar et al. INVESTIGATIONAL NEW DRUGS
- Regulation of cell cycle and RNA transcription genes identified by microarray analysis of PC-3 human prostate cancer cells treated with luteolin
- (2009) Kevin Shoulars et al. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY
- Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources
- (2009) Da Wei Huang et al. Nature Protocols
- Luteolin, a Flavonoid with Potential for Cancer Prevention and Therapy
- (2008) Yong Lin et al. CURRENT CANCER DRUG TARGETS
- Prostate cancer stem cells
- (2008) SH Lang et al. JOURNAL OF PATHOLOGY
- Prostate cancer chemotherapy in the era of targeted therapy
- (2008) A Michael et al. PROSTATE CANCER AND PROSTATIC DISEASES
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search